← Leaderboards
John M Sullivan
Va Western New York Healthcare System
$5,740,264
Attributed
$5,740,264
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $567.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,740,264 · 3
VA$0 · 2
By mechanism
R01$5,622,115 · 2
R29$118,149 · 1
I01$0 · 1
IS1$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va Western New York Healthcare System
Same institution · by research overlap
Others in their field
Top investigators on “Rhodopsin”
- Krzysztof Palczewski · University Of California-Irvine$28,849,719
- Craig Montell · University Of California Santa Barbara$23,074,142
- John L Spudich · University Of Texas Hlth Sci Ctr Houston$18,566,744
- Claude Desplan · New York University$17,021,591
- Jeannie Chen · University Of Southern California$14,439,003
- Vsevolod V. Gurevich · Sun Health Research Institute$14,360,682
Research focus
RhodopsinGene TherapyMessenger RnaPre-ClinicalRetinal DegenerationPhotoreceptorsToxic EffectCatalytic RnaOpsinRna InterferenceMediatingHammerhead RibozymeProteinsMouse ModelClinical TrialsSmall Hairpin RnaSuccessTherapeutic AgentsGeneticInnovationRecombinant Adeno-Associated Virus (Raav)Preclinical TestingLeadMacular Degeneration
Grant awards (31)
Optimizing Enhanced Hammerhead Ribozymes for Retinal Nucleic Acid Therapeutics$551,850
R01 · FY2025 · EY · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2025 · VA · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2025 · VA · contact PI
Optimizing Enhanced Hammerhead Ribozymes for Retinal Nucleic Acid Therapeutics$540,069
R01 · FY2024 · EY · contact PI
Optimizing Enhanced Hammerhead Ribozymes for Retinal Nucleic Acid Therapeutics$567,111
R01 · FY2023 · EY · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2023 · VA · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2022 · VA · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2021 · VA · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2020 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$305,962
R01 · FY2019 · EY · contact PI
ShEEP Request for Upgrade to Retinal Optical Coherence Tomography Instrumentation$0
IS1 · FY2019 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$378,000
R01 · FY2018 · EY · contact PI
A RIBOZYME RESCUE STRATEGY FOR DRY AGE-RELATED MACULAR DEGENERATION$0
I01 · FY2018 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$378,000
R01 · FY2017 · EY · contact PI
A RIBOZYME RESCUE STRATEGY FOR DRY AGE-RELATED MACULAR DEGENERATION$0
I01 · FY2017 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$378,000
R01 · FY2016 · EY · contact PI
A RIBOZYME RESCUE STRATEGY FOR DRY AGE-RELATED MACULAR DEGENERATION$0
I01 · FY2016 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$378,000
R01 · FY2015 · EY · contact PI
A RIBOZYME RESCUE STRATEGY FOR DRY AGE-RELATED MACULAR DEGENERATION$0
I01 · FY2015 · VA · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2013 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$302,400
R01 · FY2012 · EY · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2012 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$302,400
R01 · FY2011 · EY · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2011 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa$315,000
R01 · FY2010 · EY · contact PI
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration$0
I01 · FY2009 · VA · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant RP$276,838
R01 · FY2006 · EY · contact PI
A Ribozyme Rescue Strategy for Autosomal Dominant RP$315,000
R01 · FY2005 · EY
A Ribozyme Rescue Strategy for Autosomal Dominant RP$279,485
R01 · FY2004 · EY
A Ribozyme Rescue Strategy for Autosomal Dominant RP$354,000
R01 · FY2003 · EY
EARLY RECEPTOR CURRENT OF RHODOPSIN ACTIVATION$118,149
R29 · FY2000 · EY